BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2524416)

  • 1. Metabolic activation of chemical carcinogens by hepatic preparations from streptozotocin-treated rats.
    Flatt PR; Bass SL; Ayrton AD; Trinick J; Ioannides C
    Diabetologia; 1989 Feb; 32(2):135-9. PubMed ID: 2524416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streptozotocin-induced diabetes modulates the metabolic activation of chemical carcinogens.
    Ioannides C; Bass SL; Ayrton AD; Trinick J; Walker R; Flatt PR
    Chem Biol Interact; 1988; 68(3-4):189-202. PubMed ID: 2975197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver, kidney and small-intestine microsomal-mediated mutagenicity of carcinogenic aromatic amines.
    Fouarge M; Mercier M; Poncelet F
    Mutat Res; 1984 Jan; 125(1):23-31. PubMed ID: 6361544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of the hepatic mixed-function oxidases by Aroclor 1254 in the hamster: comparison of Aroclor-induced rat and hamster preparations in the activation of pre-carcinogens in the Ames test.
    Hyde R; Smith JN; Ioannides C
    Mutagenesis; 1987 Nov; 2(6):477-82. PubMed ID: 3127658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DIfferential ability of Ambystoma tigrinum hepatic microsomes to produce mutagenic metabolites from polycyclic aromatic hydrocarbons and aromatic amines.
    Anderson RS; Döös EJ; Rose FL
    Cancer Lett; 1982; 16(1):33-41. PubMed ID: 6288233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High mutagenic potency of several polycyclic aromatic hydrocarbons induced by liver postmitochondrial fractions from control and xenobiotic-treated immature carp.
    Protić-Sabljić M; Kurelec B
    Mutat Res; 1983 Aug; 118(3):177-89. PubMed ID: 6348528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation of polycyclic aromatic hydrocarbons to mutagens in the Ames test by various animal species including man.
    Phillipson CE; Ioannides C
    Mutat Res; 1989 Mar; 211(1):147-51. PubMed ID: 2493576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperketonaemia markedly modulates the metabolic activation of chemical carcinogens.
    Barnett CR; Flatt PR; Ioannides C
    Chem Biol Interact; 1990; 74(3):281-9. PubMed ID: 2140715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical models for cytochrome P450 as a biomimetic metabolic activation system in mutation assays.
    Inami K; Mochizuki M
    Mutat Res; 2002 Aug; 519(1-2):133-40. PubMed ID: 12160898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of highly purified cytochrome P-450 isozymes in the activation of 4-aminobiphenyl to mutagenic products in the Ames test.
    Masson HA; Ioannides C; Gorrod JW; Gibson GG
    Carcinogenesis; 1983 Dec; 4(12):1583-6. PubMed ID: 6418403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenicity of five cyclic N-nitrosamines: assay with Salmonella typhimurium.
    Stoltz DR; Sen NP
    J Natl Cancer Inst; 1977 Feb; 58(2):393-4. PubMed ID: 319245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
    Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y
    Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of the P-450 I family of proteins by polycyclic aromatic hydrocarbons: possible relationship to their carcinogenicity.
    Ayrton AD; McFarlane M; Walker R; Neville S; Coombs MM; Ioannides C
    Toxicology; 1990; 60(1-2):173-86. PubMed ID: 2315940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity and rat-liver S9 demethylation kinetics of N-nitrosomethylaniline and its ring-substituted derivatives.
    Kroeger-Koepke MB; Andrews AW; Kupper RJ; Koepke SR; Michejda CJ
    Mutat Res; 1981 Aug; 89(4):255-67. PubMed ID: 7027031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcoholdehydrogenase as an activating enzyme for N-nitrosodiethanolamine (NDELA): in vitro activation of NDELA to a potent mutagen in Salmonella typhimurium.
    Eisenbrand G; Denkel E; Pool B
    J Cancer Res Clin Oncol; 1984; 108(1):76-80. PubMed ID: 6378917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the metabolic bioactivation of n-nitrosopyrrolidine in the rat.
    Cottrell RC; Blowers SD; Walters DG; Lake BG; Purchase R; Phillips JC; Gangolli SD
    Carcinogenesis; 1983; 4(3):311-4. PubMed ID: 6339097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsome-mediated mutagenesis in V79 Chinese hamster cells by various nitrosamines.
    Kuroki T; Drevon C; Montesano R
    Cancer Res; 1977 Apr; 37(4):1044-50. PubMed ID: 321116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds.
    De Flora S; Bennicelli C; Camoirano A; Serra D; Romano M; Rossi GA; Morelli A; De Flora A
    Carcinogenesis; 1985 Dec; 6(12):1735-45. PubMed ID: 3905042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The superiority of hamster liver microsomal fraction for activating nitrosamines to mutagens in Salmonella typhimurium.
    Lijinsky W; Andrews AW
    Mutat Res; 1983 Oct; 111(2):135-44. PubMed ID: 6355832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting metabolism and mutagenicity of dimethylnitrosamine and diethylnitrosamine.
    Frantz CN; Malling HV
    Cancer Res; 1975 Sep; 35(9):2307-14. PubMed ID: 1097107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.